Mechanism of Action
Selenium acts through a specific form: selenocysteine, sometimes called the 21st amino acid. The human genetic code reserves a dedicated codon for its insertion into proteins. This specialised machinery reflects the biological importance of the element.
Within the cell, selenoproteins form a coordinated network. Some neutralise peroxides (toxic oxygen derivatives) using glutathione as a substrate. Others regenerate exhausted cellular defences, restoring their protective capacity. This continuous cycle preserves membrane and DNA integrity during every cell division. A third group ensures the conversion of thyroid hormones to their biologically active form.
When intake decreases, the body prioritises. It allocates available selenium first to the brain and endocrine glands. Peripheral tissues are served last. This triage explains why suboptimal status can impair certain functions long before producing visible signs.
Key Benefits
- Strong
A better-supported immune system: selenium contributes to the normal function of the immune system. Clinical data show this support is most pronounced in adults whose dietary intake stays below recommendations.
- Strong
Cells better shielded from oxidative wear: selenium contributes to the protection of cells from oxidative stress. Several controlled trials note that selenomethionine supplementation raises plasma antioxidant enzyme activity in people with initially low status.
- Strong
Thyroid hormones converted to their active form: selenium contributes to normal thyroid function. The enzymes handling this conversion are selenoproteins, placing the trace element at the heart of basal metabolic regulation.
- Moderate
A cardiovascular benefit in the over-70s: the KiSel-10 trial measured a significant drop in cardiovascular mortality in this age group. Participants received selenium and coenzyme Q10 for four years, with the benefit still present at 12-year follow-up.
- Moderate
Hair and nails preserved over time: selenium contributes to the maintenance of normal hair and nails. Selenoproteins protect the hair follicles, the root of the hair, from oxidative damage.
- Moderate
A key role in male fertility: selenium contributes to normal spermatogenesis. Testicular tissue is among the richest in selenium of the whole body, a sign of its structural role in sperm maturation.
Dosage & Forms
Three families of selenium forms exist on the market. Inorganic forms (sodium selenite, sodium selenate) are the least expensive but offer limited tissue retention. Selenised yeast provides a spectrum of selenium compounds close to dietary sources, with batch-to-batch variability in composition. Pure L-selenomethionine, the form selected by Singular, combines high oral bioavailability with a composition defined to the microgram.
The recommended nutrient intake in Europe is 70 µg per day for adults. The European upper safety limit is 300 µg per day from all sources combined. Singular calibrates the selenium dose in micrograms (µg) based on individual biological profile, within this window. The goal is to reach optimal status without exceeding the threshold beyond which the U-shaped curve reverses.
In the Singular Formula
Inclusion rationale
Selenium contributes to the protection of cells against oxidative stress, to the normal functioning of the immune system, to normal thyroid function and to the maintenance of normal hair and nails. The human genome encodes 25 selenoproteins, including glutathione peroxidases (enzymes that neutralize hydrogen peroxide and lipid hydroperoxides) and thioredoxin reductases, involved in regenerating intracellular antioxidant systems. In selenomethionine form, selenium is non-specifically incorporated into body proteins in place of methionine, creating a reservoir mobilizable according to the body's needs. Selenium content in European soils is generally lower than in North American soils, resulting in variable dietary intakes across regions. The deiodinases, enzymes responsible for converting thyroxine (T4) to triiodothyronine (T3, the active form), are themselves selenoproteins. Selenium and iodine (also present in the formula) therefore work in tandem to support normal thyroid function.
Selected form
L-selenomethionine, an organic form of selenium where the selenium atom replaces sulphur in methionine, an essential amino acid. This form exactly replicates the selenium naturally present in food (cereals, Brazil nuts, legumes). Unlike inorganic forms (selenite, selenate), selenomethionine is recognised by intestinal amino acid transporters, providing significantly higher oral bioavailability. Selenium contributes to the normal function of the immune system and to the protection of cells from oxidative stress. Quality: vegan, non-GMO, allergen-free.
Formula dosage
0 to 150 µg.
Synergies in the formula
Safety & Precautions
Selenium has several decades of track record in supplementation. Selenomethionine shows favourable digestive tolerance at nutritional doses.
The European upper safety limit is set at 300 µg per day from all dietary and supplementary sources combined. Beyond this threshold, chronic excessive intake can trigger selenosis. It presents as garlic-like breath, brittle nails and hair loss. These signs are reversible upon discontinuation of excessive supplementation.
Selenium supplementation is not recommended for individuals whose serum status is already elevated. The SELECT trial identified an increased risk of type 2 diabetes in a supplemented group whose baseline status was adequate. This observation reinforces the relevance of an approach calibrated to individual biological profile.
Pregnant or breastfeeding women should consult a healthcare professional before any supplementation. Documented drug interactions are rare, but selenium may interact with certain medications containing heavy metals.
Scientific Studies
| Authors | Year | Type | Journal | |
|---|---|---|---|---|
| Vinceti M et al. | 2018 | Meta-analysis | Cochrane Database of Systematic Reviews | View on PubMed |
Selenium for preventing cancer Cochrane systematic review of 83 studies concluding that selenium supplementation does not reduce overall cancer risk, with a signal of increased type 2 diabetes risk at high doses. | ||||
| Rayman MP | 2012 | Systematic Review | The Lancet | View on PubMed |
Selenium and human health Landmark review on the biological functions of selenium, the U-shaped dose-response relationship and implications for supplementation. | ||||
| Lippman SM et al. | 2009 | Randomised Controlled Trial | JAMA | View on PubMed |
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) Large-scale randomised trial showing no benefit of 200 µg/day selenium supplementation on prostate cancer risk in men with already adequate status. | ||||
| Alehagen U et al. | 2018 | Randomised Controlled Trial | PLoS One | View on PubMed |
Still reduced cardiovascular mortality 12 years after supplementation with selenium and coenzyme Q10 for four years: a validation of previous 10-year follow-up results of a prospective randomized double-blind placebo-controlled trial in elderly 12-year follow-up of the KiSel-10 trial confirming persistent reduction in cardiovascular mortality after four years of selenium and coenzyme Q10 co-supplementation in elderly subjects. | ||||
| Rayman MP et al. | 2018 | Randomised Controlled Trial | Free Radical Biology and Medicine | View on PubMed |
Effect of long-term selenium supplementation on mortality: Results from a multiple-dose, randomised controlled trial PRECISE controlled trial evaluating three doses of selenised yeast over five years. No overall mortality reduction, but a favourable signal in the subgroup with the lowest baseline status. | ||||
| Stranges S et al. | 2007 | Randomised Controlled Trial | Annals of Internal Medicine | View on PubMed |
Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial Post-hoc analysis of the NPC trial showing an association between 200 µg/day selenium supplementation and increased type 2 diabetes risk, mainly in subjects with high baseline status. | ||||